English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Press release submission | Aug 8, 2019

NEXUS HEALTH SYSTEMS: First Integrative Neurorehabilitation™ program in the country launches at Nexus Neurorecovery Center, augmenting the healing process for brain injured patients

+ Community
Press release submission | Aug 2, 2019

PENNSYLVANIA PATIENT SAFETY AUTHORITY: Selects MedStar Health Research Institute to Improve Patient Safety through Innovative Machine Learning

+ Technology/Innovation
Press release submission | Aug 1, 2019

I-MAB BIOPHARMA: I-Mab Biopharma and TRACON Pharmaceuticals Announce Dosing of the First Patient in a Phase 1 Trial of the CD73 Antibody TJD5 in the U.S. in Patients with Advanced Solid Tumors

+ Regulatory
John Severance | Jul 30, 2019

CAHC blames health system lobby for slowing progress on surprise billing ban

+ Regulatory
Press release submission | Jul 24, 2019

FH FOUNDATION: Individuals Had More Heart Attacks and Strokes When Cholesterol-lowering Drug Prescription Was Rejected or Unfilled

+ Regulatory
Press release submission | Jul 23, 2019

BAYER: Daily Aspirin Still Recommended for Millions of Americans Who Have Had a Heart Attack or Ischemic Stroke

+ Technology/Innovation
Press release submission | Jul 19, 2019

BACKPACK HEALTH: Patients with Hereditary Hemorrhagic Telangiectasia (HHT) Gain Full Access to Critical Health Data Management Platform

+ Community
Press release submission | Jul 18, 2019

AMERICAN RED CROSS: Red Cross Campaign Motivates Nearly 300,000 Blood Donors to Fill Missing Types for Patients in Need

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones

  • « First
  • «
  • …
  • 338
  • 339
  • 340
  • 341
  • 342
  • 343
  • 344
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily